Infection incidence, timing, and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study.

Lara D Veeken,Merel Opdam,Lise M Verhoef,Calin Popa,Reinout van Crevel,Alfons A den Broeder

Rheumatology (Oxford, England)（2023）

引用 0|浏览9

暂无评分

摘要

Ultra-low dosing (200 mg) of RTX is associated with a lower risk of infections in RA. Future interventions focusing on ultra-low dosing and slow release of RTX (e.g. by subcutaneous administration) may lower infection risk.

查看译文

关键词

RA, rituximab, infection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要